Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)

Paroxysmal nocturnal haemoglobinuria (PNH) is a clonal haematopoietic stem cell disease that presents with haemolytic anaemia, thrombosis and bone marrow failure. We report a case of a 51-year-old male with a history of PNH in treatment with Eculizumab admitted to our Hospital for acute chest pain a...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Amendola, G. Paternoster, S. P Pascale, R. Nuccorini, M. D'Amora, G. Pittella, R. D'Ascoli, F. Prestipino, G. Luzi, M. Pizzuti
Format: Article
Language:English
Published: Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2021-04-01
Series:Общая реаниматология
Subjects:
Online Access:https://www.reanimatology.com/rmt/article/view/2050
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849242781114957824
author A. Amendola
G. Paternoster
S. P Pascale
R. Nuccorini
M. D'Amora
G. Pittella
R. D'Ascoli
F. Prestipino
G. Luzi
M. Pizzuti
author_facet A. Amendola
G. Paternoster
S. P Pascale
R. Nuccorini
M. D'Amora
G. Pittella
R. D'Ascoli
F. Prestipino
G. Luzi
M. Pizzuti
author_sort A. Amendola
collection DOAJ
description Paroxysmal nocturnal haemoglobinuria (PNH) is a clonal haematopoietic stem cell disease that presents with haemolytic anaemia, thrombosis and bone marrow failure. We report a case of a 51-year-old male with a history of PNH in treatment with Eculizumab admitted to our Hospital for acute chest pain and dyspnoea. The diagnosis was a triple vessel disease and patient was scheduled for coronary artery bypass grafting surgery. To balance the risk between thrombosis and bleeding in this particular clinical setting, we decided to use thromboelastography (TEG) as point of care solution and we used the R parameter as the target of our anticoagulant therapy. The R parameter between 11 and 14 sec can be used as a target value to balance the risk; in addition, there was no evidence of acute hemolysis during the surgery and supplemental dose of Eculizumab was administered in order to minimize any potential exacerbation of intravascular hemolysis.
format Article
id doaj-art-c6838b3b1b584ffbb3aae6ea32649788
institution Kabale University
issn 1813-9779
2411-7110
language English
publishDate 2021-04-01
publisher Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
record_format Article
series Общая реаниматология
spelling doaj-art-c6838b3b1b584ffbb3aae6ea326497882025-08-20T03:59:40ZengFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, RussiaОбщая реаниматология1813-97792411-71102021-04-01172273610.15360/1813-9779-2021-2-27-361785Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)A. Amendola0G. Paternoster1S. P Pascale2R. Nuccorini3M. D'Amora4G. Pittella5R. D'Ascoli6F. Prestipino7G. Luzi8M. Pizzuti9Hematology and HSC Transplant CenterDepartment of Cardiac Surgery and Cardiovascular Intensive Care Azienda Ospedaliera Regionale San CarloHematology and HSC Transplant CenterHematology and HSC Transplant CenterDepartment of Cardiac Surgery and Cardiovascular Intensive Care Azienda Ospedaliera Regionale San CarloDepartment of Cardiac Surgery and Cardiovascular Intensive Care Azienda Ospedaliera Regionale San CarloDepartment of Cardiac Surgery and Cardiovascular Intensive Care Azienda Ospedaliera Regionale San CarloDepartment of Cardiac Surgery and Cardiovascular Intensive Care Azienda Ospedaliera Regionale San CarloDepartment of Cardiac Surgery and Cardiovascular Intensive Care Azienda Ospedaliera Regionale San CarloHematology and HSC Transplant CenterParoxysmal nocturnal haemoglobinuria (PNH) is a clonal haematopoietic stem cell disease that presents with haemolytic anaemia, thrombosis and bone marrow failure. We report a case of a 51-year-old male with a history of PNH in treatment with Eculizumab admitted to our Hospital for acute chest pain and dyspnoea. The diagnosis was a triple vessel disease and patient was scheduled for coronary artery bypass grafting surgery. To balance the risk between thrombosis and bleeding in this particular clinical setting, we decided to use thromboelastography (TEG) as point of care solution and we used the R parameter as the target of our anticoagulant therapy. The R parameter between 11 and 14 sec can be used as a target value to balance the risk; in addition, there was no evidence of acute hemolysis during the surgery and supplemental dose of Eculizumab was administered in order to minimize any potential exacerbation of intravascular hemolysis.https://www.reanimatology.com/rmt/article/view/2050paroxysmal nocturnal haemoglobinuriaeculizumabthromboelastogram
spellingShingle A. Amendola
G. Paternoster
S. P Pascale
R. Nuccorini
M. D'Amora
G. Pittella
R. D'Ascoli
F. Prestipino
G. Luzi
M. Pizzuti
Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)
Общая реаниматология
paroxysmal nocturnal haemoglobinuria
eculizumab
thromboelastogram
title Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)
title_full Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)
title_fullStr Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)
title_full_unstemmed Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)
title_short Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)
title_sort coronary artery by pass grafting in patient with paroxysmal nocturnal hemoglobinuria case report
topic paroxysmal nocturnal haemoglobinuria
eculizumab
thromboelastogram
url https://www.reanimatology.com/rmt/article/view/2050
work_keys_str_mv AT aamendola coronaryarterybypassgraftinginpatientwithparoxysmalnocturnalhemoglobinuriacasereport
AT gpaternoster coronaryarterybypassgraftinginpatientwithparoxysmalnocturnalhemoglobinuriacasereport
AT sppascale coronaryarterybypassgraftinginpatientwithparoxysmalnocturnalhemoglobinuriacasereport
AT rnuccorini coronaryarterybypassgraftinginpatientwithparoxysmalnocturnalhemoglobinuriacasereport
AT mdamora coronaryarterybypassgraftinginpatientwithparoxysmalnocturnalhemoglobinuriacasereport
AT gpittella coronaryarterybypassgraftinginpatientwithparoxysmalnocturnalhemoglobinuriacasereport
AT rdascoli coronaryarterybypassgraftinginpatientwithparoxysmalnocturnalhemoglobinuriacasereport
AT fprestipino coronaryarterybypassgraftinginpatientwithparoxysmalnocturnalhemoglobinuriacasereport
AT gluzi coronaryarterybypassgraftinginpatientwithparoxysmalnocturnalhemoglobinuriacasereport
AT mpizzuti coronaryarterybypassgraftinginpatientwithparoxysmalnocturnalhemoglobinuriacasereport